Original news and analysis on international IP policy
By William New As delegates to the annual World Intellectual Property Organization General Assemblies work through questions of organisational leadership and credibility this week, they may be looking forward to a return to agenda items related to policy. And according…
Por David Cronin para Intellectual Property Watch BRUSELAS – Aumenta la preocupación tanto en Europa como en los países en desarrollo sobre si diversos acuerdos de libre comercio, cuya firma está programada para finales del presente año, contendrán normas demasiado…
par Tove Iren S. Gerhardsen Bien qu’il n’en soit qu’à un stade embryonnaire, le projet de créer une Organisation panafricaine de propriété intellectuelle (OPAPI) se heurterait déjà à des oppositions, notamment inspirées par la crainte de voir l’Afrique s’engager sur…
By Paul Garwood Intellectual property can help improve public health, but drug research costs must be controlled so patients in poor countries can afford urgently needed medicines, a World Intellectual Property Organization symposium heard Wednesday. The Geneva-staged event, at which…
By David Cronin for Intellectual Property Watch BRUSSELS – Concern is growing in both Europe and developing countries about whether a series of free trade agreements slated for signature later this year will contain overly stringent rules on intellectual property.…
By Jia Hepeng for Intellectual Property Watch
BEIJING - China is proposing a fund to help its enterprises cope with rising international litigation related to intellectual property rights (IPRs).
The message, together with other measures, was delivered by Zhang Qin, deputy director of the State Intellectual Property Office (SIPO) at a national corporate IPR meeting on 2 September, but it was not made public until 10 September.
Sun Pingping, a spokeswoman of SIPO, confirmed the news, saying the scale and detailed operation of the fund have not been finalised.
Zhang told the corporate meeting that international legal cases on IP that Chinese enterprises face have been growing. While some of the lawsuits arise from Chinese enterprises' poor IPR awareness and ownership, it is possible that some multinationals are abusing IPR to block the rise of Chinese firms, he said.
By Dugie Standeford for Intellectual Property Watch
A European Commission ruling and record fine was upheld Monday against US software giant Microsoft for breaching European antitrust laws in a judgment that will have repercussions for intellectual property owners far beyond the case itself, experts said.
The European Court of First Instance upheld the �497 million fine and the 2004 ruling by the Commission that Microsoft had, among other things, refused access to rivals to IP-protected information needed for developing interoperable products.
By Paul Garwood More technical assistance to developing countries, closer collaboration between UN agencies and overhauling the World Intellectual Property Organization were among calls made during a conference of leading players in the intellectual property community held Monday. The conference,…
By Catherine Saez
In order to explore the relationship between intellectual property rights and life science innovations, the World Intellectual Property Organization (WIPO) is organising policy symposia to identify and clarify the intellectual property dimension in the life sciences.
In a world where biotechnology is booming and new technological frontiers are being crossed, new challenges arise such as ethical questions relating to the implication and applications of biological research. Patent agencies, industry and civil society were invited on 4 September to share their thoughts and experience on the use of the intellectual property system in bioethics.
As Antony Taubman, acting director of the WIPO Global IP Issues Division described it, biotechnology is based on living organisms which raises distinct ethical questions.
By Paul Garwood Kenya’s Parliament has rejected a proposal to revoke the government’s powers to issue compulsory licenses to manufacture products such as generic medicines without patent holder approval, a move welcomed Friday by supporters of universal access to pharmaceuticals.…